Home » Authors » Karen Carey

Karen Carey

Articles

ARTICLES

Cardiome Pharma, Fujisawa Enter $68M Cardio Drug Deal

Oct. 17, 2003

By Karen Carey

With Two Products In Clinic, GTx Seeking $86.25M In IPO

Oct. 17, 2003

By Karen Carey

Immunex, Abgenix Revise Plans To Advance ABX-EGF For Cancer

Oct. 16, 2003

By Karen Carey

CoTherix Acquires Schering's U.S. Rights For Ventavis, Raises $55M

Oct. 15, 2003

By Karen Carey

The company formerly known as Exhale Therapeutics Inc. has acquired a new name, a new financing and new U.S. rights to a pulmonary hypertension product. (BioWorld Today)

Xcyte Seeking $75M In Second Attempt At Initial Public Offering

Oct. 14, 2003

By Karen Carey

XOMA, Millennium Drop Heart Drug; CAB-2 Product Remains

Oct. 13, 2003

By Karen Carey

ID Biomedical Raising $100M To Advance FluINsure, StreptAvax

Oct. 10, 2003

By Karen Carey

CTI Raises $56M In Series B; Asthma Product To Benefit

Oct. 9, 2003

By Karen Carey

IntraBiotics Raises $19.2M For Pivotal Iseganan Trials

Oct. 8, 2003

By Karen Carey

Cubist Signs Chiron As Ex-U.S. Partner For Cubicin Marketing

Oct. 6, 2003

By Karen Carey

View All Articles by Karen Carey

Karen Carey

ARTICLES

Cardiome Pharma, Fujisawa Enter $68M Cardio Drug Deal

With Two Products In Clinic, GTx Seeking $86.25M In IPO

Immunex, Abgenix Revise Plans To Advance ABX-EGF For Cancer

CoTherix Acquires Schering's U.S. Rights For Ventavis, Raises $55M

Xcyte Seeking $75M In Second Attempt At Initial Public Offering

XOMA, Millennium Drop Heart Drug; CAB-2 Product Remains

ID Biomedical Raising $100M To Advance FluINsure, StreptAvax

CTI Raises $56M In Series B; Asthma Product To Benefit

IntraBiotics Raises $19.2M For Pivotal Iseganan Trials

Cubist Signs Chiron As Ex-U.S. Partner For Cubicin Marketing

Today's news in brief

Today's news in brief

Blenrep misstep? ODAC cites tox, GSK dosing neglect in MM

Atai Therapeutics discovers new 5-HT2A receptor partial agonists

PHD inhibitors reported in Akebia Therapeutics patent